Journal of Pediatric and Adolescent Gynecology
Volume 22, Issue 5 , Pages e99-e103 , October 2009

Occurrence of Two Rare Malignant Neoplasms (Breast and Ovarian) in an Adolescent Female

  • Yasmin Jayasinghe, MBBS
    • ,
  • Patricia S. Simmons, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Patricia S. Simmons, MD, Department of Pediatric & Adolescent Medicine, Mayo Clinic, 200 First St SW, Rochester MN 55905

References 

  1. Valdes E, Boolbol S, Cohen JM. Malignant transformation of a breast fibroadenoma to cystosarcoma phyllodes: case report and review of the literature. Am Surg. 2005;71:348
  2. Reddick RL, Shin TK, Sawheny D, et al. Stromal proliferations of the breast: an ultrastructural and immunohistochemical evaluation of cystosarcoma phylloides, juvenile fibroadenoma and fibroadenoma. Hum Pathol. 1987;18:14
  3. Laufer J, Augarten A, Szeinberg A, et al. Pathological case of the month. Arch Pediatr Adolesc Med. 1994;148:1067
  4. Seijo L, Sidhu J, Mizrachy B, et al. Malignant phyllodes tumor of the breast. Int J Surg Pathol. 1995;3:17
  5. Noguchi S, Yokouchi H, Aihara T, et al. Progression of fibroadenoma to phyllodes tumor demonstrated by clonal analysis. Cancer. 1995;76:1779
  6. Briggs R, Walters M, Rosenthal D. Cystosarcoma phylloides in adolescent female patients. Am J Surg. 1983;146:712
  7. Mollitt D, Golladay E, Gloster E, et al. Cystosarcoma phylloides in the adolescent female. J Ped Surg. 1987;22:907
  8. Mindikoglu A, Atan K. Recurrent cystosarcoma phylloides of breast: extensive full-thickness excision of chest wall with immediate repair using steel mesh and a latissimus dorsi myocutaneous flap. Br J Plast Surg. 1983;36:519
  9. Greydanus DE, Parks DS, Farrel EG. Breast disorders in children and adolescents. Pediatr Clin North Am. 1989;36:601
  10. Kenda J. Fatal metastatic cystosarcoma phylloides in a young woman. Arch Surg. 1983;118:871
  11. Hines J, Murad T, Beal J. Prognostic indicators in cystosarcoma phylloides. Am J Surg. 1987;153:276
  12. Selamzade M, Gidener C, Koyuncuoglu M, et al. Borderline phylloides in an 11 year old girl. Pediatr Surg Int. 1999;15:427
  13. Bissett D, Mallon E, Reed N, et al. Cystosarcoma phylloides: heterogeneity in a rare tumor type. J R Coll Surg Edinb. 1996;41:244
  14. Hopkins M, McGowan T, Rawlings G, et al. Phylloides tumor of the breast: a report of 14 cases. J Surg Oncol. 1994;56:108
  15. Gojnic M, Dugalic V, Vidakovic S, et al. Breast cancer and borderline ovarian carcinoma in young patients – a case report. Eur J Gynaecol Oncol. 2005;26:579
  16. Ehren IM, Mahour GH. Isaacs H Jr. Benign and malignant ovarian tumors in children and adolescents: a review of 63 cases. Am J Surg. 1984;147:339
  17. Van Winter JT, Simmons PS, Podratz KC. Surgically treated adnexal masses in infancy, childhood, and adolescence. Am L Obstet Gynecol. 1994;170:1780
  18. Deprest J, Moerman P, Corneillie P, et al. Ovarian borderline mucinous tumor in a premenarchal girl: A review on ovarian epithelial cancer in young girls. Gynecol Oncol. 1992;45:219
  19. Menzcer J, Sadetzki S, Murad H, et al. Childhood and adolescent ovarian malignant tumors in Israel. Acta Obstet Gynecol Scand. 1999;78:813
  20. Tsai J, Saigo P, Brown C, et al. Diagnosis, pathology, staging, treatment and outcome of epithelial ovarian neoplasia in patients age <21 years. Cancer. 2001;91:2065
  21. Morowitz M, Huff D, von Allmen D. Epithelial ovarian tumors in children: a retrospective analysis. J Ped Surg. 2003;38:331
  22. deSilva KS, Kanamakala S, Grover SR, et al. Ovarian lesions in children and adolescents – an 11 year review. J Pediatr Endocrinol Metab. 2004;17:951
  23. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER∗Stat Databases: Incidence - SEER 13 Regs Public-Use, Nov 2004 Sub for Expanded Races (1992-2002) and Incidence - SEER 13 Regs excluding AK Public-Use, Nov 2004 Sub for Hispanics (1992-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
  24. Eltabbakh GH, Natarajan N, Piver S, et al. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynaecol Oncol. 1999;74:103
  25. Stratton JF, Thompson D, Bobrow L, et al. The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet. 1999;65:1725
  26. Singer G, Oldt R, Cohen Y, et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003;95:484
  27. Hogg R, Friedlander M. Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. J Clin Oncol. 2004;22:1315
  28. Geisler J, Geisler H, Wiemann M, et al. Quantification of p53 in epithelial ovarian cancer. Gynecol Oncol. 1997;66:435
  29. Mazoyer S, Lalle P, Moyret-Lalle C, et al. Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations. Oncogene. 1994;9:1237
  30. Malkin D, Jolly KW, Barbier N, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992;326:1309
  31. Bot F, Sleddens H, Dinjens W. Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma. Diagn Mol Pathol. 1998;7:295
  32. Birch J, Alston R, McNally R, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene. 2001;20:4621
  33. Nogales F, Musto M, Saez A, et al. Multifocal intrafollicular granulose cell tumor of the ovary associated with an unusual germline p53 mutation. Mod Pathol. 2004;17:868
  34. The IARC TP53 mutation database. Available: http://www.iarc.fr/p53/. Last update: October 28, 2003.
  35. Yonemoto T, Tatezaki S, Ishii T, et al. Multiple primary cancers in patients with osteosarcoma. Influence of anticancer drugs and genetic factors. Am J Clin Oncol. 2004;27:220
  36. Contarini O, Urdaneta L, Hagan W, et al. Cystosarcoma phylloides of the breast: a new therapeutic proposal. Am Surg. 1982;48:157
  37. Fernandez-Aguilar S, Buxant F, Noel J. Benign phyllodes tumor associated with Maffucci's syndrome. Breast. 2004;13:247
  38. Coffin C, Cassity J, Viskochil D, et al. Non-neurogenic sarcomas in four children and young adults with neurofibromatosis type 1. Am J Med Gen. 2004;127A:40
  39. Fechner RE, Mills SE. Cartilagenous lesions. In:  Fechner RE,  Mills SE editor. Tumors of the bones and joints. 3rd ed.. Washington, DC: Armed Forces Institute of Pathology; 1993;p. 79–91
  40. Gebhart JB, Roche PC, Keeney GL, et al. Assessment of inhibin and p53 in granulose cell tumors of the ovary. Gynecol Oncol. 2000;77:232
  41. Limacher JM, Frebourg T, Natarajan AS, et al. Two metachronous tumors in the radiotherapy fields of a patient with Li Fraumeni Syndrome. Int J Cancer. 2001;96:238
  42. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility adopted on February 20, 1996. J Clin Oncol. 1996;14:1730
  43. Seeber B, Driscoll D. Hereditary breast and ovarian cancer syndrome: should we test adolescents?. J Pediatr Adolesc Gynecol. 2004;17:161
  44. Waite KA, Eng C. Protean PTEN: form and function. Am J Human Genet. 2002;70:829
  45. Hildenbrand C, Burgdorf W, Lautenschlager S. Cowden Syndrome: diagnostic skin signs. Dermatology. 2001;202:362
  46. Lu Y, Birdsall S, Osin P, et al. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer. 1997;20:275

 This paper was presented in part at the North American Society for Pediatric & Adolescent Gynecology Annual Meeting in Orlando, Florida, May 2006.

PII: S1083-3188(06)00338-X

doi: 10.1016/j.jpag.2006.11.005

Journal of Pediatric and Adolescent Gynecology
Volume 22, Issue 5 , Pages e99-e103 , October 2009

Article Tools